Leiomyosarcoma Clinical Trials in Baltimore, MD

Leiomyosarcoma Clinical Trials in Baltimore, MD

View the best 10 leiomyosarcoma medical studies in Baltimore, Maryland. Access promising new therapies by applying to a Baltimore-based Leiomyosarcoma clinical trial.

Top rated leiomyosarcoma clinical trials in Baltimore, Maryland

Here are the top 7 medical studies for leiomyosarcoma in Baltimore, Maryland

Image of The Ottawa Hospital - General Campus in Ottawa, Canada.

Surgery

Recruiting2 awardsPhase 3
This trialtests if chemo before surgery can help people with a certain type of cancer live longer.
Image of Sarcoma Oncology Research Center in Santa Monica, United States.

Unesbulin +1 More

Chemotherapy

Recruiting0 awardsPhase 2 & 3
This trial will compare two different treatments for leiomyosarcoma, a type of cancer. One treatment will be the standard of care, and the other will be a new treatment that includes a drug called unesbulin. The trial will look at whether the new treatment is more effective and has fewer side effects than the standard treatment.
Image of Children's Hospital of Orange County (Pediatrics [up to 25 years old]) in Orange, United States.

Tabelecleucel

Virus Therapy

Recruiting1 awardPhase 2
This trial will test a new treatment for diseases caused by the Epstein-Barr virus.
Image of Dana-Farber - Harvard Cancer Center LAO in Boston, United States.

Pegylated Liposomal Doxorubicin Hydrochloride +1 More

Anti-tumor antibiotic

Recruiting1 awardPhase 1
This trial tests a new chemo combo to treat advanced sarcoma, aiming to shrink/stabilize the tumor cells.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Olaparib +1 More

PARP inhibitor

Recruiting1 awardPhase 2 & 3
This trial is comparing the effectiveness of a combination treatment using olaparib and temozolomide to the common chemotherapy drugs trabectedin or pazopanib. The trial is for patients
Image of Mayo Clinic Arizona in Phoenix, United States.

Anlotinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 3
This trial is currently recruiting patients with alveolar soft part sarcoma only and is no longer recruiting patients with synovial sarcoma or leiomyosarcoma.
Image of Dana-Farber Cancer Institute in Boston, United States.

Ribociclib +1 More

CDK 4/6 Inhibitor

Recruiting1 awardPhase 2
This trial is testing a combination of two drugs, Ribociclib and Everolimus, to treat patients with advanced dedifferentiated liposarcoma or leiomyosarcoma who have had at least one prior systemic therapy. The drugs will be given orally, and the trial will last until disease progression, unacceptable toxicity, or withdrawal of consent.

Popular filter options for leiomyosarcoma baltimore trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.